PharmaShots Weekly Snapshot (Oct 26 - 30, 2020)
GSK's Zejula (niraparib) Receives EC's Approval as a Treatment in Advanced Ovarian Cancer
Published: Oct 30, 2020 | Tags: Advanced, Approval, Cancer, EU, GSK, Niraparib, Ovarian, Receives, Treatment, Zejula
Published: Oct 30,2020 | Tags: AbbVie, LIMMitless, Moderate, P-III, patients, Plaque, Psoriasis, Reports, Results, Risankizumab, Severe, Skyrizi, Study
Published: Oct 30, 2020 | Tags: Agreement, Cancers, Clinical Trials, KEYTRUDA, MSD, P-II Study, Sanofi, THOR-707
AstraZenca Reports Results of Fasenra (benralizumab) in P-lllb PONENTE Trial for Asthma
Published: Oct 30, 2020 | Tags: Asthma, AstraZenca, Benralizumab, Fasenra, P-lllb, PONENTE, Trial, Report, Results
Published: Oct 30,2020 | Tags: approval, Avastin, IMbrave150, NMPA, Roche, Sorafenib, Tecentriq, Unresectable Hepatocellular Carcinoma
Published: Oct 30,2020 | Tags: AstraZenca, Atacand, Atacand Plus, Candesartan cilexetil, Candesartan, cilexetil + Hydrochlorothiazide, Cheplapharm, Expands, Supply Agreement
CStone Signs a License Agreement with LegoChem for LCB71 to Treat Multiple Cancer Indications
Published: Oct 29,2020 | Tags: CStone, LegoChem, License Agreement, New Antibody Drug, Signs
Novartis Acquires Vedere Bio for $280M
Published: Oct 29,2020 | Tags: $280M, Acquire, Novartis, Vedere Bio
Published: Oct 29,2020 | Tags: Agreement, ALS, BMS, Develop, Five-Year, Frontotemporal Dementia, Insitro, Signs, Therapies
Published: Oct 29,2020 | Tags: Boehringer Ingelheim, Clinical, COVID-19, Illness, Initiates, P-II, People, Respiratory, Severe, Targeted, Therapy, Trial
Published: Oct 29,2020 | Tags: Bamlanivimab, BLAZE-1, Lilly, LY-CoV555, New England Journal of Medicine, P-II, Reports, Results, Study
Published: Oct 29,2020 | Tags: COVID-19, P-ll/lll Trial, Regeneron, REGN-COV2, REGN10933 + REGN10987, Reports, Results
Published: Oct 28,2020 | Tags: Cream, Data, Dermavant, EADV, P-III, Pivotal, Presents, PSOARING, Results, Tapinarof
Thermo Fisher Expands its Direct-to-Patient Service Offerings
Published: Oct 28, 2020 | Tags: Clinical, Direct, Expand, Offerings, Patient, Service, Thermo Fisher, Trials
Exact Sciences to Acquire Thrive Earlier Detection for ~$2.15B
Published: Oct 28, 2020 | Tags: ~$2.15B, Acquire, Exact Sciences, Thrive Earlier Detection
Sanofi Presents Results of Olipudase Alfa in Two Clinical Studies at ASHG 2020
Published: Oct 28,2020 | Tags: ASMD, Function, Improvement, Lung, Olipudase alfa, Patients, Reports, Results, Sanofi, Spleen, Volume
Published: Oct 28,2020 | Tags: COVID-19, DARPin Therapies, Develop, License Agreement, Molecular Partners, Novartis, Option, Signs, Two
Published: Oct 28, 2020 | Tags: Approval, AstraZeneca, Dapagliflozin, DECLARE-TIMI, 58 Forxiga, Include, Label, NMPA, P-III, Receives, Results, Trial, Update
Published: Oct 27, 2020 | Tags: 2020, ACG, Affairs, Healthcare, IBD, infliximab-abda, patients, RENFLEXIS, Reports, Results, Samsung Bioepis, Studies, System, Two, Veterans
Medtronic's Abre Venous Stent Receives the US FDA's Approval to Treat Venous Outflow Obstruction
Published: Oct 27,2020 | Tags: approval, Medtronic, Obstruction, Outflow, Receives, Stent, Treat, US FDA, Venous
Published: Oct 27, 2020 | Tags: ASN Annual Meeting 2020, C3 Glomerulopathy (C3G), Iptacopan, Novartis, P-ll Study, Result
Published: Oct 27, 2020 | Tags: dupilumab, Dupixent, EoE, P-lll Study, Regeneron, Reports, Results, Virtual ACG 2020 and UEG Week 2020
CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003
Published: Oct 27, 2020 | Tags: CS1003 (anti-PD-1), CStone, EQRx, Out-Licensing Agreement, Signs, Sugemalimab (anti-PD-L1), Targeted Indication
Jazz Pharmaceuticals Acquires SpringWorks' FAAH Inhibitor Program for Post-Traumatic Stress Disorder
Published: Oct 27,2020 | Tags: Acquires, FAAH Inhibitor Program, Jazz Pharmaceutical, SpringWorks Therapeutics
Published: Oct 26,2020 | Tags: AstraZeneca, CKD, DAPA-CKD Study, Dapagliflozin, Farxiga, P-lll, Result
Published: Oct 26,2020 | Tags: Adults, Boehringer Ingelheim, Chronic Disease, Eli Lilly, HFrEF, Jardiance, Kidney, Regardless, Reports, Results, Status
AstraZeneca Resumes P-III Study of AZD1222 Against COVID-19 in the US
Published: Oct 26,2020 | Tags: Against, AstraZeneca, AZD1222, COVID-19, P-III, Resumes, Study, US
Published: Oct 26,2020 | Tags: Agreement, Cogstate, Digital Cognitive Assessment Technologies, Eisai, Expand
Bayer Acquires Asklepios for ~$4B
Published: Oct 26, 2020 | Tags: (AskBio), ~$4B, Acquires, Asklepios BioPharmaceutical, Bayer
Published: Oct 26, 2020 | Tags: Across, ALL, approval, Companion, Diagnostic, Foundation Medicine, FoundationOne CDx, Fusions, Identify, Larotrectinib, NTRK, Patients, Receives, Solid, Tumors, U.S.FDA, Vitrakvi